The exact role of major histocompatibility complex (MHC) molecules in the peripheral survival of naive T cells is controversial, as some studies have suggested that they are critically required whereas others have suggested that they are not. Here we controlled for some of the features that differed among the earlier studies, and analyzed both the survival and expansion of naive CD4+ T cells transferred into MHC syngeneic, allogeneic, or MHC negative environments. We found that naive T cells transferred into MHC negative or allogeneic environments often fail to survive because of rejection and/or competition by natural killer (NK) cells, rather than failure to recognize a particular MHC allele. In the absence of NK cells, naive CD4+ T cells survived equally well regardless of the MHC type of the host. There was, however, an MHC requirement for extensive space-induced “homeostatic” expansion. Although the first few divisions occurred in the absence of MHC molecules, the cells did not continue to divide or transit to a CD44hi phenotype. Surprisingly, this MHC requirement could be satisfied by alleles other than the restricting haplotype. Therefore, space-induced expansion and survival are two different phenomena displaying different MHC requirements. Memory CD4+ T cells, whose survival and expansion showed no requirements for MHC molecules at all, dampened the space-induced expansion of naive cells, showing that the two populations are not independent in their requirements for peripheral niches.
Skip Nav Destination
Article navigation
6 October 2003
Article|
September 29 2003
Are Major Histocompatibility Complex Molecules Involved in the Survival of Naive CD4+ T Cells?
Isabelle Grandjean,
Isabelle Grandjean
1Laboratoire d'Immunologie and INSERM U520, Institut Curie, 75005 Paris, France
Search for other works by this author on:
Livine Duban,
Livine Duban
1Laboratoire d'Immunologie and INSERM U520, Institut Curie, 75005 Paris, France
Search for other works by this author on:
Elizabeth A. Bonney,
Elizabeth A. Bonney
2The Ghost Lab, Laboratory of Cellular and Molecular Immunology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892
3Department of Obstetrics and Gynecology, University of Vermont College of Medicine, Burlington, VT 05405
Search for other works by this author on:
Erwan Corcuff,
Erwan Corcuff
4Unité des Cytokines et Développement Lymphoïde, INSERM, EMI 0101, Institut Pasteur, 75015 Paris, France
Search for other works by this author on:
James P. Di Santo,
James P. Di Santo
4Unité des Cytokines et Développement Lymphoïde, INSERM, EMI 0101, Institut Pasteur, 75015 Paris, France
Search for other works by this author on:
Polly Matzinger,
Polly Matzinger
2The Ghost Lab, Laboratory of Cellular and Molecular Immunology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892
Search for other works by this author on:
Olivier Lantz
Olivier Lantz
1Laboratoire d'Immunologie and INSERM U520, Institut Curie, 75005 Paris, France
Search for other works by this author on:
Isabelle Grandjean
1Laboratoire d'Immunologie and INSERM U520, Institut Curie, 75005 Paris, France
Livine Duban
1Laboratoire d'Immunologie and INSERM U520, Institut Curie, 75005 Paris, France
Elizabeth A. Bonney
2The Ghost Lab, Laboratory of Cellular and Molecular Immunology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892
3Department of Obstetrics and Gynecology, University of Vermont College of Medicine, Burlington, VT 05405
Erwan Corcuff
4Unité des Cytokines et Développement Lymphoïde, INSERM, EMI 0101, Institut Pasteur, 75015 Paris, France
James P. Di Santo
4Unité des Cytokines et Développement Lymphoïde, INSERM, EMI 0101, Institut Pasteur, 75015 Paris, France
Polly Matzinger
2The Ghost Lab, Laboratory of Cellular and Molecular Immunology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892
Olivier Lantz
1Laboratoire d'Immunologie and INSERM U520, Institut Curie, 75005 Paris, France
Address correspondence to Olivier Lantz, Laboratoire d'Immunologie, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Phone: 33-1-44-32-42-18; Fax: 33-1-44-32-44-44; email: [email protected]
P. Matzinger and O. Lantz contributed equally to this work.
The online version of this article contains supplemental material.
Abbreviations used in this paper: β2m, β2-microglobulin; Tg, transgenic.
Received:
June 13 2003
Revision Received:
August 06 2003
Accepted:
August 06 2003
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2003
J Exp Med (2003) 198 (7): 1089–1102.
Article history
Received:
June 13 2003
Revision Received:
August 06 2003
Accepted:
August 06 2003
Citation
Isabelle Grandjean, Livine Duban, Elizabeth A. Bonney, Erwan Corcuff, James P. Di Santo, Polly Matzinger, Olivier Lantz; Are Major Histocompatibility Complex Molecules Involved in the Survival of Naive CD4+ T Cells? . J Exp Med 6 October 2003; 198 (7): 1089–1102. doi: https://doi.org/10.1084/jem.20030963
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement